TY  JOUR
TI  Prospects for the use of janus kinase inhibitors in the treatment of ankylosing spondylitis and psoriatic arthritis. Literature review
KW  targeted synthetic drugs
KW  tofacitinib
KW  filgotinib
KW  upadacitinib
KW  psoriatic arthritis
KW  ankylosing spondylitis
KW  pharmacotearpy.
JO  Clinical Medicine and Pharmacology
AU  Fleyshman, A.V.
PY  2022
IS  7
PB  LLC Information and publishing center Innovations and investments